Compare FDC LTD. with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. DISHMAN PHARMA FDC LTD./
DISHMAN PHARMA
 
P/E (TTM) x 17.5 25.1 69.7% View Chart
P/BV x 2.4 3.3 70.8% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 FDC LTD.   DISHMAN PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-18
DISHMAN PHARMA
Mar-16
FDC LTD./
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs319374 85.2%   
Low Rs164129 127.2%   
Sales per share (Unadj.) Rs61.6197.8 31.2%  
Earnings per share (Unadj.) Rs9.921.2 46.9%  
Cash flow per share (Unadj.) Rs12.034.7 34.5%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs73.2179.9 40.7%  
Shares outstanding (eoy) m174.4080.69 216.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x3.91.3 307.9%   
Avg P/E ratio x24.311.9 204.5%  
P/CF ratio (eoy) x20.27.2 278.5%  
Price / Book Value ratio x3.31.4 235.9%  
Dividend payout %09.4 0.0%   
Avg Mkt Cap Rs m42,11820,306 207.4%   
No. of employees `0005.50.8 667.2%   
Total wages/salary Rs m2,1675,355 40.5%   
Avg. sales/employee Rs Th1,943.719,252.7 10.1%   
Avg. wages/employee Rs Th391.76,459.5 6.1%   
Avg. net profit/employee Rs Th313.72,064.1 15.2%   
INCOME DATA
Net Sales Rs m10,75115,961 67.4%  
Other income Rs m510265 192.0%   
Total revenues Rs m11,26016,226 69.4%   
Gross profit Rs m2,2674,103 55.2%  
Depreciation Rs m3511,091 32.2%   
Interest Rs m14944 1.5%   
Profit before tax Rs m2,4112,334 103.3%   
Minority Interest Rs m-50-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m671624 107.6%   
Profit after tax Rs m1,7351,711 101.4%  
Gross profit margin %21.125.7 82.0%  
Effective tax rate %27.826.7 104.2%   
Net profit margin %16.110.7 150.5%  
BALANCE SHEET DATA
Current assets Rs m7,21311,018 65.5%   
Current liabilities Rs m2,1049,517 22.1%   
Net working cap to sales %47.59.4 505.3%  
Current ratio x3.41.2 296.1%  
Inventory Days Days54110 49.3%  
Debtors Days Days2835 79.6%  
Net fixed assets Rs m6,86516,304 42.1%   
Share capital Rs m175161 108.6%   
"Free" reserves Rs m12,58612,907 97.5%   
Net worth Rs m12,76114,516 87.9%   
Long term debt Rs m64,189 0.1%   
Total assets Rs m15,04129,805 50.5%  
Interest coverage x173.23.5 4,990.6%   
Debt to equity ratio x00.3 0.2%  
Sales to assets ratio x0.70.5 133.5%   
Return on assets %11.68.9 130.5%  
Return on equity %13.611.8 115.3%  
Return on capital %19.017.5 108.1%  
Exports to sales %12.324.8 49.8%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs m1,3273,956 33.5%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m1,8894,952 38.1%   
Fx outflow Rs m0697 0.0%   
Net fx Rs m1,8894,255 44.4%   
CASH FLOW
From Operations Rs m1,4982,786 53.8%  
From Investments Rs m201-1,529 -13.2%  
From Financial Activity Rs m-1,694-941 180.0%  
Net Cashflow Rs m10316 3.3%  

Share Holding

Indian Promoters % 68.9 61.4 112.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.7 127.0%  
FIIs % 7.5 12.7 59.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 22.1 86.0%  
Shareholders   23,730 46,261 51.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   VENUS REMEDIES  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  SHASUN PHARMA  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Zooms Over 1,900 Points after Government Slashes Corporate Tax Rates(12:30 pm)

Share markets in India jumped sharply after FM Nirmala Sitharaman announced a slew of measures in her media briefing ahead of the GST Council meet.

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

FDC LTD. Announces Quarterly Results (3QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Feb 15, 2019 | Updated on Feb 15, 2019

For the quarter ended December 2018, FDC LTD. has posted a net profit of Rs 437 m (up 2.5% YoY). Sales on the other hand came in at Rs 3 bn (up 1.4% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 20, 2019 03:19 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS